The Global Leader in Business & Technology News: CEOWORLD Magazine|Tuesday, June 18, 2013
You are here: Home » Pharmasset
  • Follow Us!
EDITOR'S PICKS

Pharmasset

CEOWORLD Closing Bell – HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z, AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN

LinkedIn Corporation (NASDAQ: LNKD) a professional network on the Internet is down more than -4%, at $68.95. LinkedIn’s 180-day lock-up period ended today, adding another 24 million shares of the company available for sale. Pharmasset, Inc. (NASDAQ: VRUS) a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections is up nearly 85%, at ...Full Article

Analyst Upgrades and Downgrades SBUX, ALU, WU, UAM, BSX, GT, PSYS, CAKE, MFC, IRC, UNH, SQNM, KMB, ALXN…

Alexion ] added to Conviction Buy List, $62 target, at Goldman Sachs… BOK Financial ] upgraded to Buy, $57 target, at SunTrust… Chicago Bridge ] upgraded to Outperform, $30 ...Full Article